equillium

ChainCatcher news, according to businesswire, Nasdaq-listed biotechnology company Equillium announced the launch of a cryptocurrency reserve strategy, integrating the cryptocurrency funding reserve strategy as part of its broader financial and growth objectives.The company has a total cash and cash equivalents of approximately $11.5 million as of June 30, 2025, and has not yet disclosed which digital currencies it will purchase.